Clinical Trial Update: CAR T Cells in Mesothelin-Expressing Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating mesothelin-targeted CAR T cells in breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Mesothelin-targeted CAR-T cells (CAR-T cells targeting mesothelin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED